International Award
The Prix Galien International Awards is organized every two years. The International Committee is composed of chairs from member nations.
All approved innovations that have been granted a national Prix Galien during the preceding two years are eligible.
Prix Galien International Charter
An Unrivaled Reputation for Intellectual rigor and Integrity…
- The Prix Galien International Awards for Pharmaceutical and Medical Technology Research is organized every two years.
- The Prix Galien International Committee is composed of chairs from the member nations.
- Are eligible to compete in the Prix Galien International all marketed drugs and medical devices that have been granted a national Prix Galien.
- The Prix Galien International Ceremony will take place in a city chosen by the organizing country.
- Entries must be submitted in English online at www.prix-galien-international.org.
May 12, 2022
London, United Kingdom
Register & Engage
+ 33 622 210 455
October, 27. 2022
New-York, United Sates
2022 represents the 50th anniversary of the awards – our golden jubilee.
Committee
Best Biotechnology Product : LUXTURNA™ (voretigene neparvovec-rzyl), Novartis Pharmaceuticals Corporation and Spark Therapeutics
Best Pharmaceutical Product : Entresto® (sacubitril/valsartan), Novartis Pharmaceuticals Corporation
Best Medical Technology : Abbott’s MitraClip™ Transcatheter Mitral Valve Repair System, Abbott
Best Digital Health Solution : Huma Therapeutic’s Remote Patient Monitoring Platform, Huma
Sistema MiniMed™ 780G, Medtronic
Best Vaccine :Comirnaty®, Pfizer Inc./ BioNTech
Best Medical Technology : AAZ-LMB’s Autotest VIH
Best Biotechnology Product : Biogen’s Spinraza.
Best Pharmaceutical Product : Boehringer Ingelheim’s Jardiance
SIRTURO (Bédaquiline, Janssen)
KEYTRUDA (Pembrolizumab, MSD)
ORPHACOL (CTRS)
Pr Thomas BAUMERT, a novel target for antiviral therapy in hepatitis C
Institute of Physiology and Pathology of Hearing, National Network of Teleaudiology
Ivacaftor (Kalydeco, Vertex Pharmaceuticals)
Bocéprevir (Victrelis, MSD)
Télaprévir (Incivo, Janssen)
Ustekinumab (Stelara, Janssen)
Rivaroxaban (Xarelto, Bayer Schering)
Romiplostim (NPlate, Amgen)
Gardasil (Sanofi-Pasteur MSD)
Bortezomid (Velcade, Janssen-Cilag)
Enfuvirtide (Fuzéon, Produits Roche)
Imatinib (Glivec-Gleevec, Novartis)
Infliximab (Remicade, Schering-Plough)
Inhibiteurs des antiprotéases : indinavir (Crixivan, MSD)
Ritonavir (Norvir, Abbott)
Saquinavir (Invirase, F. Hoffmann – La Roche)
Rispéridone (Risperdal, Janssen-Cilag)
Hepatitus A vaccine (Havrix, SmithKline-Beecham)
Filgrastim (Neupogen, Roche-Amgen)
Ondansétron (Zophren, Glaxo-Wellcome)
